Amgen in $4B term loan credit agreement to finance Horizon Therapeutics acquisition
Tero Vesalainen/iStock via Getty Images         

Amgen (NASDAQ:AMGN) has signed a $4B term loan credit agreement with several banks to help fund its $27.8B acquisition of Horizon Therapeutics (NASDAQ:HZNP).
The agreement includes aÂ $2BÂ 18-monthÂ term loan trancheÂ and aÂ a $2BÂ 3-yearÂ term loan tranche.
Bank of America (BAC), Citi (C), and Goldman Sachs (GS) are several fo the banks involved in the agreement.
Read Seeking Alpha contributor William Meyers' argument for why the Horizon (HZNP) acquisition is a good deal for Amgen (AMGN) shareholders.